Skip to content
Use caution Drug recall · FDA · Published September 29, 2015

Hospira Recalls Amidate Etomidate Injection Due to Impurities

Hospira Inc. recalls Amidate (Etomidate Injection, USP) due to failed impurity specifications confirmed during stability testing.

🇺🇸 FDA recall #D-0054-2016DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. has recalled a specific lot of Amidate (Etomidate Injection, USP) because it failed impurity and degradation specifications. The issue was identified during stability testing, which confirmed out-of-specification results for the degradation product of etomidate. This is a Class III recall involving 24,100 syringes distributed nationwide. Read more at govinfonow.com/recall/43611-hospira-inc-recalls-amidate-etomidate-injection-usp-40-mg-20.

Source Summary by GovInfoNow · govinfonow.com/recall/43611-hospira-inc-recalls-amidate-etomidate-injection-usp-40-mg-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0054-2016

Cite this page

“Hospira Recalls Amidate Etomidate Injection Due to Impurities.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43611-hospira-inc-recalls-amidate-etomidate-injection-usp-40-mg-20. Based on FDA recall #D-0054-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0054-2016%22&limit=1).

The FDA announced on September 29, 2015, that Hospira Inc. is recalling Amidate (Etomidate Injection, USP) due to failed impurity specifications. The agency stated the recall was voluntary and initiated by the firm.

How to tell if you have it

  • Brand: Hospira
  • Product: Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL)
  • Packaging: LifeShield, 20 mL, Glass Abboject Syringe with male luer lock adapter
  • NDC: 0409-8060-29
  • Lot Code: 34-531-DK
  • Expiration Date: 10/01/2015
  • Quantity: 24,100 Syringes

The hazard

The recall involves out-of-specification results for a degradation product of etomidate confirmed during stability testing. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Fresenius Kabi Epinephrine Injection Recall (May 14, 2026), Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities (September 18, 2026), and QuVa Pharma Recalls Methohexital Sodium Due to Impurity Failures (June 24, 2026).

How to tell if you have this one

Check for Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL), LifeShield, 20 mL Glass Abboject Syringe with male luer lock adapter. Look for NDC 0409-8060-29 and Lot number 34-531-DK with an expiration date of 10/01/2015.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Identify Affected Stock

    Verify if your inventory matches NDC 0409-8060-29, Lot 34-531-DK, Exp 10/01/2015.

  2. Contact Manufacturer

    Reach out to Hospira Inc. for further instructions on handling the recalled syringes.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 29 days after the firm started it.

1. Firm started the recall: Sep 29, 201512. FDA classified it Class III: Oct 21, 201523. Published in FDA’s Enforcement Report: Oct 28, 201532015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many units of this product were recalled?

A total of 24,100 syringes were included in this recall.

What is the NDC number for the recalled item?

The National Drug Code (NDC) is 0409-8060-29.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0054-2016 (September 29, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0054-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA